Nalaganje...
Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children with Relapsed or Refractory B-Acute Lymphoblastic Leukemia
BACKGROUND: The treatment paradigm for patients with relapsed/refractory B-cell acute lymphoblastic leukemia (rrALL) has been revolutionized given recent clinical trials demonstrating remarkable success of immunotherapies and leading to drug approvals by United States and European agencies. We repor...
Shranjeno v:
| izdano v: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688575/ https://ncbi.nlm.nih.gov/pubmed/33098744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.28718 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|